Merlin Crossley
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
WDR5 serves in co-activation and influences genome targeting of KLF3.
Journal: Nucleic acids research
Published: August 02, 2025
Removal of promoter CpG methylation by epigenome editing reverses HBG silencing.
Journal: Nature communications
Published: December 19, 2024
Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro.
Journal: Journal of sickle cell disease
Published: May 03, 2024
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 28, 2023
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
Journal: Molecular therapy. Nucleic acids
Published: December 15, 2022
Potent and uniform fetal hemoglobin induction via base editing.
Journal: Nature genetics
Published: July 11, 2022
Effective therapies for sickle cell disease: are we there yet?
Journal: Trends in genetics : TIG
Published: April 11, 2022
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Journal: Nature genetics
Published: September 21, 2021
Last Updated: 09/26/2026